Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AB INBEV ABI Apr 20, 2018 85.49 +0.34   
 ABLYNX ABLX Apr 20, 2018 44.68 +0.13   
 ACCENTIS ACCB Apr 20, 2018 0.04 +4.76   
 ACKERMANS V.HAAREN ACKB Apr 20, 2018 146.00 +0.41   
 AEDIFICA AED Apr 20, 2018 75.20 -0.53   
 AGEAS AGS Apr 20, 2018 43.54 -0.43   
 AGFA-GEVAERT AGFB Apr 20, 2018 3.00 +0.40   
 AHOLD DEL AD Apr 20, 2018 19.46 +0.08   
 APERAM APAM Apr 20, 2018 42.66 +0.07   
 ARSEUS RCUS Apr 20, 2018 14.20 -0.49   
 ASCENCIO ASC Apr 20, 2018 51.40 -0.77   
 ATENOR GROUP ATEB Apr 20, 2018 47.30 -0.42   
 BANIMMO A BANI Apr 20, 2018 3.18 +0.95   
 BARCO BAR Apr 20, 2018 108.00 -1.10   
 BEFIMMO-SICAFI BEFB Apr 20, 2018 52.90 -1.12   
 BEKAERT BEKB Apr 20, 2018 34.82 +0.52   
 Bel20 BEL20 Apr 20, 2018 3 921.20 +0.24   
 BELRECA BELR Apr 20, 2018 103.00 0.00   
 BELUGA BELU Apr 20, 2018 1.39 0.00   
 BPOST BPOST Apr 20, 2018 18.23 -0.71   
 BQUE NAT. BELGIQUE BNB Apr 20, 2018 2 950.00 -1.01   
 BREDERODE BREB Apr 20, 2018 51.00 -0.58   
 CAMPINE CAMB Apr 20, 2018 26.00 0.00   
 CFE CFEB Apr 20, 2018 105.20 +0.57   
 CIE BOIS SAUVAGE COMB Apr 20, 2018 404.00 +1.00   
 COFINIMMO PRIV2 COFP2 Apr 20, 2018 101.00 0.00   
 COFINIMMO-SICAFI COFB Apr 20, 2018 108.00 +0.19   
 COLRUYT COLR Apr 20, 2018 45.71 +0.37   
 CONNECT GROUP CONN Apr 20, 2018 1.08 -3.57   
 D'IETEREN DIE Apr 20, 2018 35.08 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now